Humanwell Puracap Company Profile
What is the competitive landscape for HUMANWELL PURACAP
HUMANWELL PURACAP has six approved drugs.
Summary for Humanwell Puracap
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
Drugs and US Patents for Humanwell Puracap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Humanwell Puracap | NINTEDANIB ESYLATE | nintedanib esylate | CAPSULE;ORAL | 218472-002 | Jul 9, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Humanwell Puracap | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 214580-001 | Dec 20, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Humanwell Puracap | DUTASTERIDE | dutasteride | CAPSULE;ORAL | 209909-001 | Nov 21, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Humanwell Puracap | CALCITRIOL | calcitriol | CAPSULE;ORAL | 219796-002 | Feb 27, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
